Literature DB >> 12646840

Dizziness: relating the severity of vertigo to the degree of handicap by measuring vestibular impairment.

Nicolás Pérez1, Eduardo Martin, Rafael Garcia-Tapia.   

Abstract

OBJECTIVE: We sought to correlate the severity of vertigo and handicap in patients with vestibular pathology according to measures of impairment. STUDY DESIGN AND
SETTING: We conducted a prospective assessment of patients with dizziness by means of caloric, rotatory test, and computerized dynamic posturography to estimate impairment. Handicap and severity of vertigo were determined with specific questionnaires (Dizziness Handicap Inventory and UCLA-DQ).
RESULTS: A fair relationship were found between severity of dizziness and vestibular handicap. When impairment was taken into consideration, values were still fair and only moderate for a group of patients with an abnormal caloric test as the only pathologic finding. The composite score from the sensory organization test portion of the computerized dynamic posturography is fairly correlated to severity of vertigo and handicap in the whole population of patients, but no correlation was found when they were assigned to groups of vestibular impairment.
CONCLUSION: To assess vestibular impairment, the results from several tests must be taken into account. However, vestibular handicap is not solely explained with measurements of impairment and/or severity.

Entities:  

Mesh:

Year:  2003        PMID: 12646840     DOI: 10.1067/mhn.2003.102

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  17 in total

1.  Head movements in patients with vestibular lesion: a novel approach to functional assessment in daily life setting.

Authors:  Tamara Mijovic; Jerôme Carriot; Anthony Zeitouni; Kathleen E Cullen
Journal:  Otol Neurotol       Date:  2014-12       Impact factor: 2.311

2.  Directional asymmetries and age effects in human self-motion perception.

Authors:  Rachel E Roditi; Benjamin T Crane
Journal:  J Assoc Res Otolaryngol       Date:  2012-03-09

3.  Dizziness impairs health-related quality of life.

Authors:  M Ten Voorde; H J van der Zaag-Loonen; R B van Leeuwen
Journal:  Qual Life Res       Date:  2011-09-01       Impact factor: 4.147

Review 4.  What vestibular tests to choose in symptomatic patients after a cochlear implant? A systematic review and meta-analysis.

Authors:  Moumainn Abouzayd; Paul F Smith; Sylvain Moreau; Martin Hitier
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-08       Impact factor: 2.503

5.  Is there a relationship between objective and subjective assessment of balance in elderly patients with instability?

Authors:  Marcos Rossi-Izquierdo; Sofía Santos-Pérez; María Del-Río-Valeiras; Antonio Lirola-Delgado; Ana Faraldo-García; Isabel Vaamonde-Sánchez-Andrade; Pilar Gayoso-Diz; Andrés Soto-Varela
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-12       Impact factor: 2.503

6.  What is the most effective vestibular rehabilitation technique in patients with unilateral peripheral vestibular disorders?

Authors:  Marcos Rossi-Izquierdo; Sofia Santos-Pérez; Andrés Soto-Varela
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-22       Impact factor: 2.503

7.  Preoperative audiovestibular handicap in patients with vestibular schwannoma.

Authors:  Rachel L Humphriss; David M Baguley; Patrick R Axon; David A Moffat
Journal:  Skull Base       Date:  2006-11

8.  Is psychogenic dizziness the exact diagnosis?

Authors:  Fazil Necdet Ardiç; Figen Culha Ateşci
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-18       Impact factor: 2.503

9.  Suprathreshold asymmetries in human motion perception.

Authors:  Rachel E Roditi; Benjamin T Crane
Journal:  Exp Brain Res       Date:  2012-05-05       Impact factor: 1.972

10.  Vertigo Associated With Cochlear Implant Surgery: Correlation With Vertigo Diagnostic Result, Electrode Carrier, and Insertion Angle.

Authors:  Charlotte Weinmann; Uwe Baumann; Martin Leinung; Timo Stöver; Silke Helbig
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.